Compare SUVEN LIFE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES ABBOTT INDIA SUVEN LIFESCIENCES/
ABBOTT INDIA
 
P/E (TTM) x 19.2 43.1 44.5% View Chart
P/BV x 3.9 12.4 31.5% View Chart
Dividend Yield % 0.5 0.6 97.1%  

Financials

 SUVEN LIFESCIENCES   ABBOTT INDIA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ABBOTT INDIA
Mar-18
SUVEN LIFESCIENCES/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3386,110 5.5%   
Low Rs1693,996 4.2%   
Sales per share (Unadj.) Rs52.11,552.2 3.4%  
Earnings per share (Unadj.) Rs6.8188.8 3.6%  
Cash flow per share (Unadj.) Rs8.6196.4 4.4%  
Dividends per share (Unadj.) Rs1.5055.00 2.7%  
Dividend yield (eoy) %0.61.1 54.4%  
Book value per share (Unadj.) Rs65.3796.6 8.2%  
Shares outstanding (eoy) m127.2821.25 599.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.3 149.4%   
Avg P/E ratio x37.126.8 138.7%  
P/CF ratio (eoy) x29.625.7 115.0%  
Price / Book Value ratio x3.96.3 61.2%  
Dividend payout %22.029.1 75.4%   
Avg Mkt Cap Rs m32,272107,376 30.1%   
No. of employees `0001.13.3 32.6%   
Total wages/salary Rs m6613,937 16.8%   
Avg. sales/employee Rs Th6,132.29,929.3 61.8%   
Avg. wages/employee Rs Th611.11,185.1 51.6%   
Avg. net profit/employee Rs Th803.51,207.7 66.5%   
INCOME DATA
Net Sales Rs m6,63532,985 20.1%  
Other income Rs m2421,170 20.7%   
Total revenues Rs m6,87734,155 20.1%   
Gross profit Rs m1,6045,245 30.6%  
Depreciation Rs m221162 136.8%   
Interest Rs m3838 98.7%   
Profit before tax Rs m1,5876,215 25.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7182,203 32.6%   
Profit after tax Rs m8694,012 21.7%  
Gross profit margin %24.215.9 152.1%  
Effective tax rate %45.235.4 127.6%   
Net profit margin %13.112.2 107.7%  
BALANCE SHEET DATA
Current assets Rs m6,23222,655 27.5%   
Current liabilities Rs m1,4906,681 22.3%   
Net working cap to sales %71.548.4 147.6%  
Current ratio x4.23.4 123.3%  
Inventory Days Days8665 133.4%  
Debtors Days Days8329 283.3%  
Net fixed assets Rs m4,043835 484.0%   
Share capital Rs m127213 59.9%   
"Free" reserves Rs m8,18316,715 49.0%   
Net worth Rs m8,31016,928 49.1%   
Long term debt Rs m180-   
Total assets Rs m10,38924,162 43.0%  
Interest coverage x43.1163.7 26.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.4 46.8%   
Return on assets %8.716.8 52.1%  
Return on equity %10.523.7 44.1%  
Return on capital %19.536.9 52.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,622369 1,525.4%   
Fx outflow Rs m1,7993,807 47.3%   
Net fx Rs m3,822-3,438 -111.2%   
CASH FLOW
From Operations Rs m3561,527 23.3%  
From Investments Rs m-279-2,148 13.0%  
From Financial Activity Rs m-225-1,024 22.0%  
Net Cashflow Rs m-148-1,646 9.0%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.1 213.5%  
Shareholders   37,287 18,270 204.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Sep 13, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS